Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape

Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape

HMP CME

1 month
14 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Earn CME: https://www.naccme.com/program/19-cpc-101-2 This webcast features a presentation by Dr. Gabriella Hobbs that examines the most recent evidence-based guidelines to optimize individualized tyrosine kinase inhibitor (TKI) selection for chronic myeloid leukemia (CML) patients based on disease phase, treatment history, genetic mutation profile, and comorbidities, © 2019 NACCME, an HMP Company

Up Next Autoplay